City
Epaper

AstraZeneca COVID-19 vaccine will be tested in kids as young as 6

By ANI | Updated: February 13, 2021 19:50 IST

University researchers plan to start testing AstraZeneca's coronavirus vaccine on children as young as six in Britain on Saturday.

Open in App

University researchers plan to start testing AstraZeneca's coronavirus vaccine on children as young as six in Britain on Saturday.

According to CNN, a team at the University of Oxford, which developed the vaccine, said it will test the vaccine on children and teens aged 6-17 there and at sites in London, Southampton and Bristol. Few trials of coronavirus vaccine involve children as yet. In the US, Pfizer/BioNTech's and Moderna's vaccines are being tested in children as young as 12.

"This new trial, a single-blind, randomized Phase II trial, will enrol 300 volunteers, with up to 240 of these volunteers receiving the (AstraZeneca) vaccine and the remainder a control meningitis vaccine, which has been shown to be safe in children but is expected to produce similar reactions, such as a sore arm," the Oxford team said in a statement, according to CNN.

Grace Li, a pediatric researcher in the Oxford Vaccine Group, said in a statement: "We've already seen that the vaccine is safe and effective in adults, and our understanding of how children are affected by the coronavirus continues to evolve."

CNN reported that while children are much less likely than adults to be hospitalised or die from COVID-19, children are as just as likely as adults to become infected.

"While most children are relatively unaffected by (the) coronavirus and are unlikely to become unwell with the infection, it is important to establish the safety and immune response to the vaccine in children and young people as some children may benefit from vaccination," said Andrew Pollard, chief investigator for the trial at Oxford.

Pollard added, "These new trials will extend our understanding of the control of SARS-CoV2 to younger age groups."

This comes after the World Health Orgzation's Strategic Advisory Group of Experts (SAGE) said on Wednesday, according to Sputnik, that the benefits of the AstraZeneca/Oxford University COVID-19 vaccine outweigh the potential risks.

( With inputs from ANI )

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Tags: Grace LiAndrew pollardCNNLondonBristolAstrazenecaPremier of saFacebook groupTwitter sportsAdministrative capitalInternational data corp.State for international trade
Open in App

Related Stories

CricketChris Woakes Walks Out to Bat with Sling On as England Lose Ninth Wicket on Day 5 of ENG vs IND 5th Test (Watch Video)

CricketENG vs IND 5th Test Weather Forecast: Will Rain Play Spoilsport on Day 5 of England vs India at Oval in London?

CricketENG vs IND 5th Test Weather Forecast: Will Rain Play Spoilsport on Day 3 of England vs India at Oval in London? (VIDEO)

CricketENG vs IND 5th Test Weather Forecast: Will Rain Play Spoilsport on Day 2 of England vs India at Oval in London?

EntertainmentRakul Preet Singh Jets Off to London for Final Schedule of De De Pyaar De 2

International Realted Stories

International“Days of Ruthlessly Killing or Hurting Innocent People Are Over!”: Donald Trump Announces Federal Takeover of DC Police, Mobilisation of National Guard

InternationalJSMM Chief Shafi Burfat labels Pak army chief Asim Munir a global threat, calls for international sanctions

InternationalChina-Pakistan alliance has evolved beyond conventional arms transfers: Report

InternationalBalochistan: Rights body condemns travel ban by Pakistani authorities

InternationalPakistan-China defence alliance poses risk to regional stability: Report